OTCMKTS:PBSV Pharma-Bio Serv (PBSV) Stock Price, News & Analysis $0.61 +0.00 (+0.38%) As of 10/17/2025 10:24 AM Eastern Add Compare Share Share Stock Analysis Stock AnalysisChartDividendEarningsSEC FilingsShort InterestBuy This Stock About Pharma-Bio Serv Stock (OTCMKTS:PBSV) View Price History Chart DataSkip Price History Chart 1 Day 5 Days 30 Days 90 Days 1 Year Advanced 1 Day 1 Day 5 Days 30 Days 90 Days 1 Year Advanced Show volume Show extended hours Get Pharma-Bio Serv alerts:Sign Up Key Stats Today's Range$0.61▼$0.6150-Day Range$0.51▼$0.6952-Week Range$0.31▼$1.36Volume100 shsAverage Volume7,564 shsMarket Capitalization$14.05 millionP/E RatioN/ADividend YieldN/APrice TargetN/AConsensus RatingN/A Company Overview Pharma-Bio Serv, Inc. operates as a compliance and technology transfer services consulting firm in Puerto Rico, the United States, Europe, Brazil, and internationally. The company provides technical compliance consulting services comprising regulatory compliance, validation, technology transfer, engineering, project management, and process support for the pharmaceutical, chemical manufacturing, biotechnology, medical device, cosmetic, food industries, and allied products companies. Pharma-Bio Serv, Inc. was founded in 1993 and is headquartered in Dorado, Puerto Rico. Read More Pharma-Bio Serv Stock Analysis - MarketRank™See Top-Rated MarketRank™ Stocks3rd Percentile Overall ScorePBSV MarketRank™: Pharma-Bio Serv scored higher than 3% of companies evaluated by MarketBeat. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation. Analyst's OpinionN/AAnalyst RatingN/A Consensus RatingThere is not enough analysis data for Pharma-Bio Serv. Earnings and Valuation0.0 / 5Proj. Earnings GrowthN/A Price to Earnings Ratio vs. the MarketThe P/E ratio of Pharma-Bio Serv is -61.26, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.Price to Earnings Ratio vs. SectorThe P/E ratio of Pharma-Bio Serv is -61.26, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.Price to Book Value per Share RatioPharma-Bio Serv has a P/B Ratio of 1.02. P/B Ratios below 3 indicates that a company is reasonably valued with respect to its assets and liabilities. Short Interest3.0 / 5Short Interest LevelHealthy Percentage of Shares Shorted0.08% of the outstanding shares of Pharma-Bio Serv have been sold short.Short Interest Ratio / Days to CoverPharma-Bio Serv has a short interest ratio ("days to cover") of 0.7, which is generally considered an acceptable ratio of short interest to trading volume.Change versus previous monthShort interest in Pharma-Bio Serv has recently increased by 318.18%, indicating that investor sentiment is decreasing significantly. Dividend0.0 / 5Dividend StrengthWeak Dividend YieldPharma-Bio Serv does not currently pay a dividend.Dividend GrowthPharma-Bio Serv does not have a long track record of dividend growth.Read more about Pharma-Bio Serv's dividend. Sustainability and ESGN/AEnvironmental ScoreN/A Percentage of Shares Shorted0.08% of the outstanding shares of Pharma-Bio Serv have been sold short.Short Interest Ratio / Days to CoverPharma-Bio Serv has a short interest ratio ("days to cover") of 0.7, which is generally considered an acceptable ratio of short interest to trading volume.Change versus previous monthShort interest in Pharma-Bio Serv has recently increased by 318.18%, indicating that investor sentiment is decreasing significantly. News and Social Media0.6 / 5News SentimentN/A News SentimentPharma-Bio Serv has a news sentiment score of -1.00. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a lower news sentiment than the 0.51 average news sentiment score of Business Services companies.News Coverage This WeekMarketBeat has tracked 1 news article for Pharma-Bio Serv this week, compared to 0 articles on an average week. Company Ownership0.8 / 5Insider TradingN/A Insider Buying vs. Insider SellingIn the past three months, Pharma-Bio Serv insiders have not sold or bought any company stock.Percentage Held by Insiders12.60% of the stock of Pharma-Bio Serv is held by insiders. A high percentage of insider ownership can be a sign of company health.Read more about Pharma-Bio Serv's insider trading history. Receive PBSV Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Pharma-Bio Serv and its competitors with MarketBeat's FREE daily newsletter. Submit View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. PBSV Stock News HeadlinesPBSV Set to Implement Growth InitiativesSeptember 16, 2025 | msn.comPBSV Pharma-Bio Serv, Inc. - Seeking AlphaJune 26, 2025 | seekingalpha.comBuy alert: Move $1,000 before Tesla’s Optimus launchElon's $1,000,000,000,000 payday Elon Musk just made his biggest insider purchase of Tesla stock ever. He's preparing for a "mind blowing" new launch that could see Tesla move away from electric cars... and into a new market.October 18 at 2:00 AM | Altimetry (Ad)OTC:PBSV Financials | Pharma-Bio Serv Inc - Investing.comJune 26, 2025 | investing.comPBSV Decisions Paying OffJune 19, 2025 | msn.comPBSV Returns to GrowthMarch 18, 2025 | msn.comPharma-Bio Serv Inc.: Pharma-Bio Serv Announces Full Year ResultsJanuary 31, 2025 | finanznachrichten.dePBSV Released Earnings and Declares DividendJanuary 30, 2025 | msn.comSee More Headlines PBSV Stock Analysis - Frequently Asked Questions How have PBSV shares performed this year? Pharma-Bio Serv's stock was trading at $0.5499 on January 1st, 2025. Since then, PBSV stock has increased by 11.4% and is now trading at $0.6126. How were Pharma-Bio Serv's earnings last quarter? Pharma-Bio Serv Inc. (OTCMKTS:PBSV) released its earnings results on Monday, September, 15th. The company reported ($0.01) earnings per share (EPS) for the quarter, missing analysts' consensus estimates of $0.03 by $0.04. The firm earned $1.96 million during the quarter, compared to the consensus estimate of $3 million. Pharma-Bio Serv had a negative net margin of 0.91% and a negative trailing twelve-month return on equity of 0.68%. How do I buy shares of Pharma-Bio Serv? Shares of PBSV stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. What other stocks do shareholders of Pharma-Bio Serv own? Based on aggregate information from My MarketBeat watchlists, some other companies that Pharma-Bio Serv investors own include AT&T (T), Annaly Capital Management (NLY), BlackRock Multi-Sector Income Trust (BIT), GE Aerospace (GE), Exxon Mobil (XOM), Enterprise Products Partners (EPD) and First BanCorp. (FBP). Company Calendar Last Earnings9/15/2025Today10/18/2025Fiscal Year End10/31/2025Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeOTCMKTS SectorBusiness Services Industry Consulting Sub-IndustryBusiness Services Current SymbolOTCMKTS:PBSV CIK1304161 Webwww.pharmabioserv.com Phone(787) 278-2709Fax787-796-5168Employees185Year Founded1993Profitability EPS (Trailing Twelve Months)($0.01) Trailing P/E RatioN/A Forward P/E Ratio5.57 P/E GrowthN/ANet Income-$780 thousand Net Margins-0.91% Pretax Margin-1.23% Return on Equity-0.68% Return on Assets-0.56% Debt Debt-to-Equity RatioN/A Current Ratio7.93 Quick Ratio7.93 Sales & Book Value Annual Sales$9.51 million Price / Sales1.48 Cash FlowN/A Price / Cash FlowN/A Book Value$0.60 per share Price / Book1.02Miscellaneous Outstanding Shares22,932,000Free Float20,043,000Market Cap$14.05 million OptionableNot Optionable Beta0.76 Social Links (Almost) Everything You Need To Know About The EV MarketLooking to profit from the electric vehicle mega-trend? Enter your email address and we'll send you our list of which EV stocks show the most long-term potential.Get This Free Report This page (OTCMKTS:PBSV) was last updated on 10/18/2025 by MarketBeat.com Staff From Our PartnersThis Crypto Is Set to Explode in JanuaryCurious about crypto but still stuck scrolling endless threads? People who get in early aren’t just lucky—they...Crypto 101 Media | SponsoredMelt-up warning Porter Stansberry says this bull market is past the “safe zone” and racing toward an event horizon — and in hi...Porter & Company | SponsoredBuffett, Gates and Bezos Quietly Dumping Stocks—Here's WhyImagine a bull market so powerful, every single investor became a millionaire. Not by finding the next NVIDIA ...Banyan Hill Publishing | SponsoredMove $1,000 into this stock before Nov 6The End of Tesla? "Hold onto your Tesla stock." That's the message insiders at Tesla have been giving staff...Altimetry | SponsoredAltucher: It Looks Like My Trump prediction is coming trueNew Hampshire just launched a Strategic Crypto Reserve — and James Altucher says it’s the first sign that “Tru...Paradigm Press | SponsoredINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredShots officially fired…Elon Musk just declared war on the wireless giants with a $17 billion spectrum deal that gives SpaceX the righ...Brownstone Research | SponsoredClaim Your Share of $5.39 BILLION in AI Equity ChecksThe U.S. government just took advantage of Public Law 81-774 to crack down on AI companies... In turn, enfo...Angel Publishing | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Pharma-Bio Serv Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Pharma-Bio Serv With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.